4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-20-013642
Director sold 10,902 shares at $102.00 ($1,112,004)
- Director acquired 6,573 shares (option exercise)
- Director gave 870 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KROLL MARK W Director | 2019-12-31 | Gift | −870 | 22,747 | D: show line 1 in the form | ||
| KROLL MARK W Director | 2020-04-09 | Option exercise | +6,573 | $45.45 | $298,743 | 29,320 | D: show line 2 in the form |
| KROLL MARK W Director | 2020-04-09 | Sale | −6,573 | $102.00 | $670,446 | 22,747 | D: show line 3 in the form |
| KROLL MARK W Director | 2020-04-09 | Sale | −4,329 | $102.00 | $441,558 | 18,418 | D: show line 4 in the form |
| Open-market sales · 10,902 sh · avg $102.00 · $1,112,004 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KROLL MARK W Director | 2020-04-09 | Option exercise · Non-qualified Stock Option (Right to Buy) | −6,573 | 0 | D: show line 5 in the form |
Loading xslF345X03/form4.xml…